Page last updated: 2024-08-25

nedaplatin and Hematologic Diseases

nedaplatin has been researched along with Hematologic Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, YH; Li, QQ; Liu, MZ; Wang, QX; Wang, XH; Xiao, WW; Yang, H; Zhang, WW; Zhu, YJ1
Fujita, S; Fukuhara, A; Hatachi, Y; Irisa, K; Kim, YH; Masago, K; Mio, T; Mishima, M; Nagai, H; Sakamori, Y; Togashi, Y1
Furuta, I; Kurashina, K; Kurita, H; Nozaki, S; Wada, S; Yamamoto, E1
Hojo, K; Maekawa, R; Sugita, K; Takeda, Y; Uchida, N; Yoshioka, T1

Trials

2 trial(s) available for nedaplatin and Hematologic Diseases

ArticleYear
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms, Squamous Cell; Organoplatinum Compounds; Survival Analysis; Treatment Outcome

2011
Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
    Oral oncology, 2004, Volume: 40, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Remission Induction; Taxoids; Treatment Outcome

2004

Other Studies

2 other study(ies) available for nedaplatin and Hematologic Diseases

ArticleYear
Concurrent radiotherapy and weekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinoma.
    Scientific reports, 2015, Jan-28, Volume: 5

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome

2015
Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Dose-Response Relationship, Drug; Female; Fluorouracil; Hematologic Diseases; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organoplatinum Compounds

1998